Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery

Phase 2

Recruiting

Conditions: Lung Cancer Stage II
Lung Cancer
Lung Cancer Stage III

Interventions: Drug: Cisplatin
Drug: Pemetrexed
Drug: Gemcitabine
Drug: Carboplatin
Drug: Certolizumab
Drug: Nivolumab

First Posted Date: 2021-08-05

Last Posted Date: 2024-11-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 60

Registration Number: NCT04991025

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

Fluorescent Imaging of Nerves With Illuminare-1 During Surgery

Phase 1

Recruiting

Conditions: Prostate Adenocarcinoma

Interventions: Drug: Illuminare-1
Device: Karl Storz D-Light C photodynamic diagnostic (PDD)

First Posted Date: 2021-07-30

Last Posted Date: 2024-06-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT04983862

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 3 locations

A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)

Phase 2

Active, not recruiting

Conditions: Metastatic Non Small Cell Lung Cancer
Recurrent Non Small Cell Lung Cancer

Interventions: Drug: Amivantamab
Drug: Lazertinib

First Posted Date: 2021-07-16

Last Posted Date: 2024-10-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 43

Registration Number: NCT04965090

Locations: 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States

and more 4 locations

Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome

Phase 2

Recruiting

Conditions: Mycosis Fungoides
Mycosis Fungoides/Sezary Syndrome
Sezary Syndrome
Sézary
Advanced Mycosis Fungoides

Interventions: Drug: Gemcitabine
Drug: Pembrolizumab

First Posted Date: 2021-07-14

Last Posted Date: 2024-11-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT04960618

Locations: 🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 5 locations

A Study of N9 Chemotherapy in Children With Neuroblastoma

Early Phase 1

Active, not recruiting

Conditions: Pediatric Cancer
Neuroblastoma

Interventions: Drug: Cyclophosphamide
Drug: Topotecan
Drug: Vincristine
Drug: Doxorubicin
Drug: Ifosfamide
Drug: Etoposide
Drug: Carboplatin
Drug: Mesna

First Posted Date: 2021-07-01

Last Posted Date: 2024-12-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 26

Registration Number: NCT04947501

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

Recruiting

Conditions: Solid Tumor, Unspecified, Adult
Solid Tumor
Solid Tumor, Adult

Interventions: Behavioral: CONVO intervention

First Posted Date: 2021-06-28

Last Posted Date: 2024-07-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 234

Registration Number: NCT04942717

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
SBH Health System, Bronx, New York, United States
🇺🇸
MSK at Ralph Lauren (All Protocol Activities), New York, New York, United States

and more 1 locations

A Study of a Vaccine in Combination with Β-glucan and GM-CSF in People with Neuroblastoma

Phase 2

Recruiting

Conditions: Neuroblastoma

Interventions: Dietary Supplement: β-glucan
Drug: GM-CSF
Biological: OPT-821

First Posted Date: 2021-06-23

Last Posted Date: 2024-10-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 264

Registration Number: NCT04936529

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Phase 1

Recruiting

Conditions: Primary Extra-cranial Solid Tumor
Recurrent or Refractory Glypican 3 (GPC3)

Interventions: Drug: Codrituzumab

First Posted Date: 2021-06-16

Last Posted Date: 2024-06-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT04928677

Locations: 🇺🇸
Dana Farber Cancer Institute (Data Collection Only), Boston, Massachusetts, United States
🇺🇸
Children's Hospital of Los Angeles (Data Collection Only), Los Angeles, California, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 1 locations

A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Not Applicable

Active, not recruiting

Conditions: Smoldering Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance

Interventions: Other: Plant based meals

First Posted Date: 2021-06-09

Last Posted Date: 2024-03-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 23

Registration Number: NCT04920084

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 4 locations

A Study of a Telemedicine Program for Older Adults With Cancer

Not Applicable

Active, not recruiting

Conditions: Cancer

Interventions: Other: Tele-Geriatric Oncology program

First Posted Date: 2021-06-08

Last Posted Date: 2024-04-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 124

Registration Number: NCT04917848

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy